Live monitoring of small vessels during development and disease using the flt-1 promoter element

Basic Research in Cardiology

Volumn 107, Issue 2, 2012, Pages

  Herz, Katia ^a   Heinemann, Jan C ^a   Hesse, Michael ^a   Ottersbach, Annika ^a   Geisen, Caroline ^a   Fuegemann, Christopher J ^a   Röll, Wilhelm ^a   Fleischmann, Bernd K ^a   Wenzel, Daniela ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

EGFP; Endothelium; ES cells; Flt 1; Transgenic mouse

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; VASCULOTROPIN RECEPTOR 1; DIAGNOSTIC AGENT; FLT1 PROTEIN, MOUSE; GREEN FLUORESCENT PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; FLT 1 GENE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE FUNCTION; HEART INFARCTION; HEART INJURY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MARKER GENE; MOLECULAR PROBE; MOUSE; NONHUMAN; PROMOTER REGION; QUANTITATIVE STUDY; STAINING; TRANSGENIC MOUSE; ANIMAL; CYTOLOGY; DISEASE MODEL; GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84857498950     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-012-0257-5     Document Type: Article

References (39)

1. Bernatchez PN, Soker S, Sirois MG (1999) Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is flk-1-dependent. J Biol Chem 274:31047-31054. doi:10.1074/jbc.274.43.31047
2. Breier G, Clauss M, Risau W (1995) Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development. Dev Dyn 204:228-239. doi:10.1002/aja.1002040303
3. Bremer S, Worth AP, Paparella M, Bigot K, Kolossov E, Fleischmann BK, Hescheler J, Balls M (2001) Establishment of an in vitro reporter gene assay for developmental cardiac toxicity. Toxicol In Vitro 15:215-223. doi:10.1016/S0887-2333(01) 00007-8
4. Dor Y, Camenisch TD, Itin A, Fishman GI, McDonald JA, Carmeliet P, Keshet E (2001) A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. Development 128:1531-1538
5. Fong GH, Klingensmith J, Wood CR, Rossant J, Breitman ML (1996) Regulation of flt-1 expression during mouse embryogenesis suggests a role in the establishment of vascular endothelium. Dev Dyn 207:1-10. doi:10.1002/(SICI) 1097-0177(199609)207: 1\1:AID-AJA1[3.0.CO;2-M
6. Frank NY, Schatton T, Kim S, Zhan Q, Wilson BJ, Ma J, Saab KR, Osherov V, Widlund HR, Gasser M, Waaga-Gasser AM, Kupper TS, Murphy GF, Frank MH (2011) VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth. Cancer Res 71:1474-1485
7. George SH, Gertsenstein M, Vintersten K, Korets-Smith E, Murphy J, Stevens ME, Haigh JJ, Nagy A (2007) Developmental and adult phenotyping directly from mutant embryonic stem cells. Proc Natl Acad Sci U S A 104:4455-4460. doi:10.1073/ pnas.0609277104
8. Hazarika S, Dokun AO, Li Y, Popel AS, Kontos CD, Annex BH (2007) Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1. Circ Res 101:948-956. doi:10.1161/ CIRCRESAHA.107.160630
9. Hidaka M, Stanford WL, Bernstein A (1999) Conditional requirement for the flk-1 receptor in the in vitro generation of early hematopoietic cells. Proc Natl Acad Sci USA 96:7370-7375. doi:10.1073/pnas.96.13.7370
10. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, Zhu Z, Hicklin D, Wu Y, Port JL, Altorki N, Port ER, Ruggero D, Shmelkov SV, Jensen KK, Rafii S, Lyden D (2005) VEGFR1- positive haematopoietic bone marrow progenitors initiate the premetastatic niche. Nature 438:820-827. doi:10.1038/nature04186
11. Kolossov E, Bostani T, Roell W, Breitbach M, Pillekamp F, Nygren JM, Sasse P, Rubenchik O, Fries JW, Wenzel D, Geisen C, Xia Y, Lu Z, Duan Y, Kettenhofen R, Jovinge S, Bloch W, Bohlen H, Welz A, Hescheler J, Jacobsen SE, Fleischmann BK (2006) Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med 203:2315-2327. doi:10.1084/ jem.20061469
12. Krijnen PA, Hahn NE, Kholova I, Baylan U, Sipkens JA, van Alphen FP, Vonk AB, Simsek S, Meischl C, Schalkwijk CG, van Buul JD, van Hinsberg VW, Niessen HW (2012) Loss of DPP4 activity is related to a prothrombogenic status of endothelial cells: implications for the coronary microvasculature of myocardial infarction patients. Basic Res Cardiol 107:1-13. doi:10.1007/ s00395-011-0233-5
13. Lahteenvuo JE, Lahteenvuo MT, Kivela A, Rosenlew C, Falkevall A, Klar J, Heikura T, Rissanen TT, Vahakangas E, Korpisalo P, Enholm B, Carmeliet P, Alitalo K, Eriksson U, Yla-Herttuala S (2009) Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms. Circulation 119:845-856. doi: 10.1161/CIRCULATIONAHA.108.8164
14. Lassaletta AD, Chu LM, Sellke FW (2011) Therapeutic neovascularization for coronary disease: current state and future prospects. Basic Res Cardiol 106:897-909. doi:10.1007/s00395-011-0200-1
15. Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, Simons M (1996) VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol 270:H1803-H1811
16. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De KB, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert JM, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ, Carmeliet P (2002) Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-flt1. Nat Med 8:831-840. doi:10.1038/nm731
17. Malan D, Wenzel D, Schmidt A, Geisen C, Raible A, Bolck B, Fleischmann BK, Bloch W (2012) Endothelial beta-1 integrins regulate sprouting and network formation during vascular development. Development 137:993-1002. doi:10.1242/dev.045377
18. Marchetti S, Gimond C, Iljin K, Bourcier C, Alitalo K, Pouyssegur J, PagesG(2002) Endothelial cells genetically selected from differentiating mouse embryonic stem cells incorporate at sites of neovascularization in vivo. J Cell Sci 115:2075-2085
19. Marti HH, Risau W (1998) Systemic hypoxia changes the organspecific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci USA 95:15809-15814. doi: 10.1073/pnas.95.26.15809
20. Milberg P, Klocke R, Frommeyer G, Quang TH, Dieks K, Stypmann J, Osada N, Kuhlmann M, Fehr M, Milting H, Nikol S, Waltenberger J, Breithardt G, Eckardt L (2011) G-CSF therapy reduces myocardial repolarization reserve in the presence of increased arteriogenesis, angiogenesis and connexin 43 expression in an experimental model of pacing-induced heart failure. Basic Res Cardiol 106:995-1008. doi:10.1007/s00395-011-0230-8
21. Nagy A, Gocza E, Diaz EM, Prideaux VR, Ivanyi E, Markkula M, Rossant J (1990) Embryonic stem cells alone are able to support fetal development in the mouse. Development 110:815-821
22. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z (1999) Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9-22
23. Oerlemans MI, Goumans MJ, van MB, Clevers H, Doevendans PA, Sluijter JP (2012). Active Wnt signaling in response to cardiac injury. Basic Res Cardiol 105:631-641. doi:10.1007/s00395- 010-0100-9
24. Ohtani K, Dimmeler S (2011) Control of cardiovascular differentiation by microRNAs. Basic Res Cardiol 106:5-11. doi: 10.1007/s00395-010-0139-7
25. Peters KG, De VC, Williams LT (1993) Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 90:8915-8919. doi:10.1073/pnas.90.19.8915
26. Quinn G, Ochiya T, Terada M, Yoshida T (2000) Mouse flt-1 promoter directs endothelial-specific expression in the embryoid body model of embryogenesis. Biochem Biophys Res Commun 276:1089-1099. doi:10.1006/bbrc.2000. 3602
27. Redick SD, Bautch VL (1999) Developmental platelet endothelial cell adhesion molecule expression suggests multiple roles for a vascular adhesion molecule. Am J Pathol 154:1137-1147. doi: 10.1016/S0002-9440(10)65366-7
28. Roell W, Lewalter T, Sasse P, Tallini YN, Choi BR, Breitbach M, Doran R, Becher UM, Hwang SM, Bostani T, von MJ, Hofmann A, Reining S, Eiberger B, Gabris B, Pfeifer A, Welz A, Willecke K, Salama G, Schrickel JW, Kotlikoff MI, Fleischmann BK (2007) Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 450:819-824. doi:10.1038/nature 06321
29. Roell W, Lu ZJ, Bloch W, Siedner S, Tiemann K, Xia Y, Stoecker E, Fleischmann M, Bohlen H, Stehle R, Kolossov E, Brem G, Addicks K, Pfitzer G, Welz A, Hescheler J, Fleischmann BK (2002) Cellular cardiomyoplasty improves survival after myocardial injury. Circulation 105:2435-2441. doi:10.1161/ 01.CIR.0000016063.66513.BB
30. Sacchetti A, El ST, Nasr AF, Alberti S (2001) Efficient GFP mutations profoundly affect mRNA transcription and translation rates. FEBS Lett 492:151-155. doi:10.1016/S0014-5793(01) 02246-3
31. Stankunas K, Ma GK, Kuhnert FJ, Kuo CJ, Chang CP (2010) VEGF signaling has distinct spatiotemporal roles during heart valve development. Dev Biol 347:325-336
32. Ulyatt C, Walker J, Ponnambalam S (2011) Hypoxia differentially regulates VEGFR1 and VEGFR2 levels and alters intracellular signaling and cell migration in endothelial cells. Biochem Biophys Res Commun 404:774-779
33. Wenzel D, Knies R, Matthey M, Klein AM, Welschoff J, Stolle V, Sasse P, Roll W, Breuer J, Fleischmann BK (2009) Beta(2)- adrenoceptor antagonist ICI 118,551 decreases pulmonary vascular tone in mice via a G(i/o) protein/nitric oxide-coupled pathway. Hypertension 54:157-163. doi:10.1161/HYPERTEN SIONAHA.109.130468
34. Wenzel D, Rieck S, Vosen S, Mykhaylyk O, Trueck C, Eberbeck D, Trahms L, Zimmeremann K, Pfeifer A, Fleischmann BK (2012) Identification of magnetic nanoparticles for combined positioning and lentiviral transduction of endothelial cells. Pharm Res. doi:10.1007/s11095-011-0657-5
35. Witmer AN, Dai J, Weich HA, Vrensen GF, Schlingemann RO (2002) Expression of vascular endothelial growth factor receptors 1, 2, and 3 in quiescent endothelia. J Histochem Cytochem 50:767-777. doi:10.1177/002215540205000603
36. 2+ channel blockers. Differentiation 48: 173-182
37. Wu J, Li J, Zhang N, Zhang C (2011) Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation. Basic Res Cardiol 106:317-324. doi:10.1007/ s00395-011-0168-x
38. Xiao J, Moon M, Yan L, Nian M, Zhang Y, Liu C, Lu J, Guan H, Chen M, Jiang D, Jiang H, Liu PP, Li H (2012) Cellular FLICEinhibitory protein protects against cardiac remodelling after myocardial infarction. Basic Res Cardiol 107:1-21. doi:10.1007/ s00395-011-0239-x
39. Zentilin L, Puligadda U, Lionetti V, Zacchigna S, Collesi C, Pattarini L, Ruozi G, Camporesi S, Sinagra G, Pepe M, Recchia FA, Giacca M (2010) Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction. FASEB J 24:1467-1478